基于甲胺的纳米药物用于重编程瘤免疫微环境
Jieyu Liu1, Xiaoling Li1, Yinggang Li1
1Department of Radiology, Huaxi MR Research Center (HMRRC), Institution of Radiology and Medical Imaging, Breast Center, Institute of Breast Health Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
Theranostics
|January 8, 2025
概括
甲胺纳米药物在重新编程免疫抑制瘤微环境 (TME) 中表现有前途. 这种方法调节免疫代谢以增强抗瘤免疫力,为癌症治疗提供新的途径.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 纳米医学是一种纳米医学.
背景情况:
- 免疫疗法已推进癌症治疗,但面临着来自免疫抑制瘤微环境 (TME) 的挑战.
- 氨酸单酸激活蛋白激酶 (AMPK) 对于细胞能量和抗瘤免疫是至关重要的.
- 糖尿病药物梅特福明激活AMPK,但它的癌症治疗作用仍在争论中.
研究的目的:
- 审查基于甲胺的纳米药物在克服TME介导免疫抑制方面的作用.
- 在癌症中探索甲胺纳米药物的免疫代谢重编程潜力.
主要方法:
- 对甲胺,纳米药物,AMPK通路和TME研究的文献综述.
- 通过甲胺配方对免疫代谢调节的研究分析.
主要成果:
- 甲胺,特别是在纳米药物配方中,可以重新编程免疫抑制的TME.
- 这种重编程涉及瘤和免疫细胞的免疫代谢调节.
- 基于甲胺的纳米药物显示出增强抗瘤免疫反应的潜力.
结论:
- 基于甲胺的纳米药物为癌症免疫治疗提供了一个有前途的战略.
- 通过metformin纳米药物准免疫代谢可以克服TME诱导的免疫逃避.
- 这种方法为开发下一代癌症疗法提供了宝贵的见解.
相关概念视频
01:27Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K